Have a personal or library account? Click to login
Prevalence of Metabolic Syndrome in Psoriatic Arthritis and Rheumatoid Arthritis Cover

Prevalence of Metabolic Syndrome in Psoriatic Arthritis and Rheumatoid Arthritis

Acta Marisiensis - Seria Medica
Volume 60 (2014): Issue 5 (October 2014)
By: Lucia Crăciun,  P Crăciun and  F Buicu  
Open Access
|Dec 2014

References

  1. 1. .Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol. 2008;7:373-377.
    Search in Google Scholar
  2. 2. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000-1006.10.1093/eurheartj/ehp567289473620037179
    Search in Google Scholar
  3. 3. Jamnitski A, Symmons D, Peters MJ, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72:211-216.10.1136/annrheumdis-2011-20119422532629
    Search in Google Scholar
  4. 4. Ramonda R, Lo Nigro A, Modesti V, et al. Atherosclerosis in psoriatic arthritis. Autoimmun Rev. 2011;10:773-778.10.1016/j.autrev.2011.05.02221684355
    Search in Google Scholar
  5. 5. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36:203-209.10.1016/j.semarthrit.2006.09.00117067658
    Search in Google Scholar
  6. 6. Vitale C, Marazzi G, Volterrani M, et al. Metabolic syndrome. Minerva Med. 2006;97:219-229.
    Search in Google Scholar
  7. 7. Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metabolic Syndrome and Related Disorders. 2010;8:331-334.10.1089/met.2009.0124312970120367239
    Search in Google Scholar
  8. 8. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009;11:R110.10.1186/ar2765274579219607680
    Search in Google Scholar
  9. 9. Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H. The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis. 2011;14:248-254.10.1111/j.1756-185X.2011.01595.x21816020
    Search in Google Scholar
  10. 10. Karakoca M, Batmaza I, Sariyildiza MA, et al. The Relationship of Metabolic Syndrome With Disease Activity and the Functional Status in Patients With Rheumatoid Arthritis. J Clin Med Res. 2012;4:279-285.10.4021/jocmr1001w340962422870176
    Search in Google Scholar
  11. 11. Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT. Prevalence of Atherosclerotic Risk Factors and the Metabolic Syndrome in Patients With Chronic Inflammatory Arthritis. Arthritis Care & Research. 2011,63:195-202.10.1002/acr.2036320890981
    Search in Google Scholar
  12. 12. Matei C., Pop I., Jurcuț R, et al. Romanian Multicentric Study of the Prevalence of Metabolic Syndrome - ROMES, Hellenic Journal of Cardiology, 2008: 49: 303-309.
    Search in Google Scholar
  13. 13. Tracy Y. Zhu, Edmund K. Li, Lai-Shan Tam. Cardiovascular Risk in Patients with Psoriatic Arthritis. Int J Rheumatol. 2012; 2012:714321.
    Search in Google Scholar
  14. 14. Madanagobalane S , Anandan S . Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian Journal of Dermatology. 2012;27:353-357.
    Search in Google Scholar
  15. 15. Sahebari M, Goshayeshi L, Mirfeizi Z, et al. Investigation of the Association between Metabolic Syndrome and Disease Activity in Rheumatoid Arthritis. The Scientific World Journal, 2011;11:1195-1205.10.1100/tsw.2011.111572008421666989
    Search in Google Scholar
  16. 16. Sattar N, McCarey D, Capell H, McInnes I. Explaining how ‘highgrade’ systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-2963.10.1161/01.CIR.0000099844.31524.0514676136
    Search in Google Scholar
  17. 17. Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756-763.10.1016/j.atherosclerosis.2007.01.00417266963
    Search in Google Scholar
  18. 18. Karvounaris SA, Sidiropoulos PI, Papadakis JA, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007;66:28-33.10.1136/ard.2006.053488179840616793841
    Search in Google Scholar
  19. 19. Escalante A, Haas R, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165:1624-1629.10.1001/archinte.165.14.162416043681
    Search in Google Scholar
DOI: https://doi.org/10.2478/amma-2014-0041 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 196 - 199
Submitted on: Jun 13, 2014
|
Accepted on: Oct 19, 2014
|
Published on: Dec 4, 2014
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
metabolic syndrome,
psoriatic arthritis,
rheumatoid arthritis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2014 Lucia Crăciun, P Crăciun, F Buicu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 60 (2014): Issue 5 (October 2014)Next article